Whereas the percentages of tumor-infiltrating CD4+ and CD8+ T cells only slightly changed with tumor progression (online supplemental figure S1D, E), most of the T cells expressed either one of the inhibitory receptors PD-1 and TIM-3 or both (figure 1C). This evidence concerns the gene HAVCR2 and neoplasm.